Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

USA - NASDAQ:ASLE - US00810F1066 - Common Stock

8.38 USD
+0.04 (+0.48%)
Last: 9/22/2025, 9:26:18 PM
8.54 USD
+0.16 (+1.91%)
After Hours: 9/22/2025, 9:26:18 PM
Fundamental Rating

5

Taking everything into account, ASLE scores 5 out of 10 in our fundamental rating. ASLE was compared to 69 industry peers in the Aerospace & Defense industry. The financial health of ASLE is average, but there are quite some concerns on its profitability. ASLE is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ASLE was profitable.
ASLE had a positive operating cash flow in the past year.
Of the past 5 years ASLE 4 years were profitable.
In multiple years ASLE reported negative operating cash flow during the last 5 years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a Return On Assets of 1.01%. This is comparable to the rest of the industry: ASLE outperforms 46.38% of its industry peers.
ASLE has a Return On Equity of 1.56%. This is comparable to the rest of the industry: ASLE outperforms 47.83% of its industry peers.
The Return On Invested Capital of ASLE (1.70%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.01%
ROE 1.56%
ROIC 1.7%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

With a Profit Margin value of 1.86%, ASLE perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
In the last couple of years the Profit Margin of ASLE has declined.
The Operating Margin of ASLE (3.65%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ASLE has declined.
Looking at the Gross Margin, with a value of 30.44%, ASLE is in the better half of the industry, outperforming 68.12% of the companies in the same industry.
In the last couple of years the Gross Margin of ASLE has declined.
Industry RankSector Rank
OM 3.65%
PM (TTM) 1.86%
GM 30.44%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASLE is destroying value.
ASLE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ASLE has been increased compared to 5 years ago.
The debt/assets ratio for ASLE has remained at the same level compared to a year ago.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ASLE has an Altman-Z score of 2.39. This is not the best score and indicates that ASLE is in the grey zone with still only limited risk for bankruptcy at the moment.
ASLE's Altman-Z score of 2.39 is on the low side compared to the rest of the industry. ASLE is outperformed by 65.22% of its industry peers.
ASLE has a debt to FCF ratio of 9.61. This is a negative value and a sign of low solvency as ASLE would need 9.61 years to pay back of all of its debts.
ASLE's Debt to FCF ratio of 9.61 is in line compared to the rest of the industry. ASLE outperforms 59.42% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ASLE is not too dependend on debt financing.
The Debt to Equity ratio of ASLE (0.28) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 9.61
Altman-Z 2.39
ROIC/WACC0.17
WACC10.12%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ASLE has a Current Ratio of 3.87. This indicates that ASLE is financially healthy and has no problem in meeting its short term obligations.
ASLE has a Current ratio of 3.87. This is amongst the best in the industry. ASLE outperforms 82.61% of its industry peers.
A Quick Ratio of 0.82 indicates that ASLE may have some problems paying its short term obligations.
ASLE's Quick ratio of 0.82 is on the low side compared to the rest of the industry. ASLE is outperformed by 76.81% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 0.82
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 300.00% over the past year.
The Earnings Per Share has been growing by 22.36% on average over the past years. This is a very strong growth
Looking at the last year, ASLE shows a decrease in Revenue. The Revenue has decreased by -1.12% in the last year.
The Revenue has been growing slightly by 0.45% on average over the past years.
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
Revenue 1Y (TTM)-1.12%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%

3.2 Future

Based on estimates for the next years, ASLE will show a very strong growth in Earnings Per Share. The EPS will grow by 87.10% on average per year.
Based on estimates for the next years, ASLE will show a quite strong growth in Revenue. The Revenue will grow by 13.65% on average per year.
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

ASLE is valuated quite expensively with a Price/Earnings ratio of 29.93.
73.91% of the companies in the same industry are more expensive than ASLE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.41, ASLE is valued at the same level.
A Price/Forward Earnings ratio of 12.35 indicates a correct valuation of ASLE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ASLE indicates a rather cheap valuation: ASLE is cheaper than 97.10% of the companies listed in the same industry.
ASLE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 29.93
Fwd PE 12.35
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ASLE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ASLE is cheaper than 82.61% of the companies in the same industry.
ASLE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ASLE is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.68
EV/EBITDA 15.87
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASLE's earnings are expected to grow with 87.10% in the coming years.
PEG (NY)0.19
PEG (5Y)1.34
EPS Next 2Y88.94%
EPS Next 3Y87.1%

0

5. Dividend

5.1 Amount

No dividends for ASLE!.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (9/22/2025, 9:26:18 PM)

After market: 8.54 +0.16 (+1.91%)

8.38

+0.04 (+0.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners52.15%
Inst Owner Change0.76%
Ins Owners8.83%
Ins Owner Change18.71%
Market Cap395.37M
Analysts45.71
Price Target7.14 (-14.8%)
Short Float %3.79%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)197.96%
Min EPS beat(2)-157.67%
Max EPS beat(2)553.6%
EPS beat(4)1
Avg EPS beat(4)91.87%
Min EPS beat(4)-157.67%
Max EPS beat(4)553.6%
EPS beat(8)2
Avg EPS beat(8)22.76%
EPS beat(12)3
Avg EPS beat(12)-11.28%
EPS beat(16)7
Avg EPS beat(16)29.34%
Revenue beat(2)1
Avg Revenue beat(2)-3.02%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)21.94%
Revenue beat(4)2
Avg Revenue beat(4)-4.37%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)21.94%
Revenue beat(8)3
Avg Revenue beat(8)-11.05%
Revenue beat(12)3
Avg Revenue beat(12)-14.59%
Revenue beat(16)6
Avg Revenue beat(16)-7.59%
PT rev (1m)7.69%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.83%
EPS NY rev (1m)0%
EPS NY rev (3m)295.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.26%
Valuation
Industry RankSector Rank
PE 29.93
Fwd PE 12.35
P/S 1.13
P/FCF 32.68
P/OCF 17.53
P/B 0.95
P/tB 1.05
EV/EBITDA 15.87
EPS(TTM)0.28
EY3.34%
EPS(NY)0.68
Fwd EY8.09%
FCF(TTM)0.26
FCFY3.06%
OCF(TTM)0.48
OCFY5.7%
SpS7.43
BVpS8.82
TBVpS7.98
PEG (NY)0.19
PEG (5Y)1.34
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.56%
ROCE 2.28%
ROIC 1.7%
ROICexc 1.72%
ROICexgc 1.85%
OM 3.65%
PM (TTM) 1.86%
GM 30.44%
FCFM 3.45%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-51.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-49.58%
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 9.61
Debt/EBITDA 3.62
Cap/Depr 54.75%
Cap/Sales 2.98%
Interest Coverage 1.92
Cash Conversion 70.72%
Profit Quality 185.88%
Current Ratio 3.87
Quick Ratio 0.82
Altman-Z 2.39
F-Score6
WACC10.12%
ROIC/WACC0.17
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.12%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A
EBIT growth 1Y7673.96%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year219.21%
EBIT Next 3Y99.33%
EBIT Next 5YN/A
FCF growth 1Y106.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.22%
OCF growth 3Y-47.9%
OCF growth 5YN/A